Published
Drugmaker Pfizer expects $15 billion in revenue from its COVID-19 vaccine in 2021 and said it can produce 2 billion doses this year, including 200 million doses for the U.S.
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
02:16
The Week in Numbers: the $100 billion question
-
01:09
Pfizer expects $15 billion in COVID-19 vaccine sales
-
01:26
Pfizer raises vaccine sales forecast to $33.5 billion
-
01:55
With no Carnival party in Brazil, vendors lose year's biggest payday
-
01:59
US steps up commitment to donate Pfizer COVID-19 vaccines, adding another half a billion shots
-
15:43
SCOTUS Eviscerates Payday Lenders For SLIMY Move
-
02:07
World's biggest drug cartels eyeing massive payday as Title 42 ends
-
05:55
College basketball star gears up for her earned payday | Nightline
-
05:00
Inside these numbers are ‘worse’ numbers: Douglas Holtz-Eakin
-
07:24
Pfizer, Moderna expected to make a combined $50 billion this year | Niko House
-
01:37
Powerball numbers drawn for record $2.04 billion jackpot l ABC News
-
01:04
Pfizer bets $2.5 billion on European output boost
-
02:33
EU vaccine deal: Pfizer-BioNTech to supply 1.8 billion doses
-
01:05
Pfizer boosts COVID shot forecasts by $2 billion
-
02:19
BVTV: Elon Musk’s payday | REUTERS
-
10:56
Gold-searching brothers continue quest for big payday
-
1:00:50
BC Budget 2021: Nearly $6 billion set aside for COVID support, forecasts $8.1-billion deficit | FULL
-
02:19
The Week in Numbers: Europe's $850 billion energy pain
-
01:41
BVTV: Telco payday
-
01:57
Pfizer, U.S. strike $2 billion COVID-19 vaccine deal
-
02:04
US Olympic athletes 'looking for their Colin Kaepernick payday': Clay Travis
-
01:35
By the Numbers: America’s $4 billion commitment to global vaccinations
Loading...